Category: Company
Industry: Drug Manufacturers - Major Quick infos Headquarters: North Chicago, Illinois, United States Trade prices Volume: 1.4M Market Cap: 271.78B Prev closed: 84.31 Open: 84.64 High: 85.15 Low: 83.94 52 week low: 62.55 52 week high: 101.28 Dividends: Next ER: April 27, 2023 Before Market Opens
About the Company AbbVie is a pharmaceutical company that discovers, develops and markets both biopharmaceuticals and small molecule drugs. It originated in 2013 as a spin-off of Abbott Laboratories.
Earnings History Date EPS / Forecast Revenue / Forecast April 27, 2023 2.46 / 2.4612.23B / 12.18BBeat! February 9, 2023 3.6 / 3.5315.12B / 15.33BJanuary 27, 2023 - / 3.75- / 15.82BOctober 28, 2022 3.66 / 3.5814.81B / 14.93BJuly 29, 2022 3.37 / 3.3214.58B / 14.66Bview more
Historical Data Date Price Open High Low Vol Change ER Jul 25, 2023 141.63 142.4 142.93
141.32
4.4M -1.08% Jul 24, 2023 143.18 143.1 144.43
142.84
4.4M -0.39% Jul 21, 2023 143.74 142.2 144.18
141.94
5.7M 1.09% Jul 20, 2023 142.19 138.84 142.72
138.55
7.0M 3.28% Jul 19, 2023 137.68 137.24 138.06
136.95
4.8M 0.81% Jul 18, 2023 136.58 134.8 137.9
134.71
5.4M 1.30% Jul 17, 2023 134.83 135.82 136.23
134.56
4.0M -0.87% Jul 14, 2023 136.01 134.73 136.62
134.12
5.5M 1.81% Jul 13, 2023 133.59 132.93 134.1
132.7
4.6M -1.03% Jul 12, 2023 134.98 135.82 136.6
134.79
4.8M -0.44% view more
NYSE - New York Stock Exchange
More profiles and info about the company Founded:1 January 2013 Employees:30,000 News
AbbVie to Host Second-Quarter 2020 Earnings Conference Call investors.abbvie.com Jul 7, 2020 8:00 pm AbbVie says Skyrizi beat Amgen’s Otezla in plaque psoriasis trial seekingalpha.com Jul 26, 2023 8:35 pm Catalyst Watch: Earnings blitz, central bank meetings, UPS strike jitters and Barbenheimer seekingalpha.com Jul 22, 2023 3:00 am AbbVie wins EU backing for Genmab-partnered lymphoma therapy seekingalpha.com Jul 21, 2023 6:43 pm Elevance Health upgraded at Morgan Stanley on BioPlus business seekingalpha.com Apr 28, 2023 1:06 am Vertex gains as AbbVie ends cystic fibrosis development program seekingalpha.com Apr 27, 2023 11:09 pm GMDA, TIGO and INAB among pre-market losers seekingalpha.com Apr 27, 2023 8:33 pm Eli Lilly, Merck among top pharma picks in Barclays Q2 preview seekingalpha.com Jul 17, 2023 AbbVie slips as Cigna adds more Humira biosimilars for coverage seekingalpha.com Jul 11, 2023 1:40 am Goldman Sachs sees rays of hope in underperforming health sector seekingalpha.com Jul 10, 2023 Dividend Roundup: Unilever, PNC Financial, Oracle, AbbVie, and more seekingalpha.com Jul 7, 2023 7:04 pm AbbVie updates full-year EPS estimate range; below consensus seekingalpha.com Jul 7, 2023 5:39 am Celltrion launches biosimilar of AbbVie's Humira in US seekingalpha.com Jul 6, 2023 12:57 am More AbbVie Humira biosimilars launched (updated) seekingalpha.com Jul 3, 2023 11:21 pm Organon launches biosimilar of AbbVie's Humira seekingalpha.com Jul 1, 2023 11:03 pm Medicare revises guidance on drug price negotiations amid lawsuits seekingalpha.com Jul 1, 2023 12:41 am Robert Michael named president and COO at AbbVie - filing seekingalpha.com Jun 30, 2023 5:28 am Morgan Stanley shakes up its global dividend portfolio seekingalpha.com Jun 29, 2023 5:08 pm CollPlant nabs $10M milestone from AbbVie for dermal filler product seekingalpha.com Jun 27, 2023 2:52 am What is behind big pharma's underperformance? seekingalpha.com Jun 26, 2023 ABBV Dividends Ex-Dividend Amount Announced Date Record Date Payment Date Jul 13, 2023 1.48 Aug 15, 2023 Apr 13, 2023 1.48 May 15, 2023 Jan 12, 2023 1.48 Feb 15, 2023 Oct 13, 2022 1.41 Nov 15, 2022 Jul 14, 2022 1.41 Aug 15, 2022 view more
Key Persons CEO : Richard A. Gonzalez CFO : Robert A. Michael Talk about AbbVie Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Homepage: abbvie.com Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
